Article Text

Download PDFPDF
EP1054 Symptom burden and operational metrics in gynecological cancer patients cared by a palliative care team, in Greece
  1. A Tserkezoglou,
  2. HA Mullali,
  3. A Tsiatsouli,
  4. H Avgetidou,
  5. J Liakopoulos,
  6. S Amoiridou,
  7. S Tsotakos and
  8. E Patiraki
  1. 'Galilee' Palliative Care Unit, Spata, Greece


Introduction/Background The integration of palliative care into standard gynecologic oncology care, in developed countries, is considered to be associated with cost-savings, longer survival, lower symptom burden, and better quality of life for patients and caregivers. ‘GALILEE’ is the first comprehensive Palliative Care Unit in Greece.

The aim of the study is to characterize symptom prevalence and identify operational metrics in patients with gynecologic cancer, cared at home by an interdisciplinary palliative care team

Methodology Retrospective analysis of all women, with gynecologic cancers, cared from 01.03.2015- 31.12.2018, by ‘GALILEE’ was performed. Electronic patient records were reviewed for demographics, disease characteristics and end of life discussions. Performance status was measured by the Palliative Performance Scale (PPS) and symptom burden by the Edmonton Symptom Assessment System (ESAS).

Results Out of 520 patients cared in the same time period, only 42 (8)%) were identified with gynecologic cancers. Their median age was 68,5 years (range, 44–94). The majority had ovarian cancer (47,6%). Half of the patients were admitted during first line treatment. Only two patients (4,7%) were referred by their gynecologic oncologist. Median time in care was 97,5 (5–2151) days.

At study entry, most patients (61%) had a good performance status (PPS>50%), while the most common disease-related symptoms were pain (78,6%), fatigue (54,8%), nausea (52,4%), anxiety (45,2%) and depression (31%). 43,9% of the patients had no emergency admission to the hospital, 42,8% of patients died of their disease and 50% were supported to die at home. In the last 2 weeks of life 7,1% of patients were receiving chemotherapy and 31% had a hospital admission.

Upon admission, only 23,8% of patients were aware of the diagnosis and 11,9% of the prognosis.

Conclusion Gynecologic oncology outpatients have a high symptom burden and information needs and could thus profit by concurrent provision of palliative care, early on their disease trajectory.

Disclosure Nothing to disclose

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.